Closure of multiple types of K+ channels is necessary to induce changes in renal vascular resistance in vivo in rats

Pflugers Arch. 2011 Nov;462(5):655-67. doi: 10.1007/s00424-011-1018-2. Epub 2011 Aug 27.

Abstract

Inhibition of K(+) channels might mediate renal vasoconstriction. As inhibition of a single type of K(+) channel caused minor or no renal vasoconstriction in vivo in rats, we hypothesized that several classes of K(+) channels must be blocked to elicit renal vasoconstriction. We measured renal blood flow (RBF) in vivo in anesthetized Sprague-Dawley rats. Test agents were infused directly into the renal artery to avoid systemic effects. Inhibition of BK(Ca) and K(ir) channels (with TEA and Ba(2+), respectively) caused small and transient reductions in RBF (to 93 ± 2% and 95 ± 1% of baseline, respectively). K(ATP), SK(Ca) or K(v) channel blockade (with glibenclamide, apamin and 4-aminopyridine, respectively) was without effect. However, a cocktail of all blockers caused a massive reduction of RBF (to 15 ± 10% of baseline). Nifedipine and mibefradil abolished and reduced, respectively, this RBF reduction. The effect of the cocktail of K(+) channel blockers was confirmed in mice using the isolated blood-perfused juxtamedullary nephron preparation. A cocktail of K(+) channel openers (K(+), NS309, NS1619 and pinacidil) had only a minor effect on baseline RBF in vivo in rats, but reduced the vasoconstriction induced by bolus injections of norepinephrine or angiotensin II (by 33 ± 5% and 60 ± 5%, respectively). Our results indicate that closure of numerous types of K(+) channels could participate in the mediation of agonist-induced renal vasoconstriction. Our results also suggest that renal vasoconstriction elicited by K(+) channel blockade is mediated by nifedipine-sensitive Ca(2+) channels and partly by mibefradil-sensitive Ca(2+) channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arterioles / drug effects
  • Benzimidazoles / pharmacology
  • Calcium Channels / drug effects
  • Calcium Channels / physiology*
  • Large-Conductance Calcium-Activated Potassium Channels / drug effects
  • Male
  • Membrane Potentials / drug effects
  • Mibefradil / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / physiology
  • Nifedipine / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels / agonists
  • Potassium Channels, Inwardly Rectifying / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Renal Circulation / drug effects
  • Renal Circulation / physiology*
  • Vascular Resistance / drug effects*
  • Vasoconstriction / drug effects

Substances

  • Benzimidazoles
  • Calcium Channels
  • Large-Conductance Calcium-Activated Potassium Channels
  • Potassium Channel Blockers
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • NS 1619
  • Mibefradil
  • Nifedipine